Mid Cap Healthcare
Stocks Ranked by
Market Capitalization
Mid Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 151 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $722B.
The largest by market cap are Madrigal Pharmaceuticals (MDGL) at $9.9B, State Street SPDR S&P Biotech ETF (XBI) at $9.9B and Spyre Therapeutics (SYRE) at $9.9B.
Among institutional investors, 10x Genomics (TXG) drew the most net new fund positions in Q3 2026: 153 funds opened new positions, taking total fund holders up 88 (22%) quarter-over-quarter.
- Combined market cap: $722B across 151 stocks.
- Mid Cap: market cap between $2B and $10B.
- Largest constituent: Madrigal Pharmaceuticals (MDGL), $9.9B market cap.
- Most net new fund positions in Q3 2026: 10x Genomics (TXG), +88 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.